Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-01 Sale | 2026-10-02 9:30 pm | Spyre Therapeutics Inc. | SYRE | King-Jones Heidy See Remarks | 28,933 | $91.03 | $2,633,902 | 485,323 (Direct) | View |
| 2026-09-01 Sale | 2026-09-03 9:34 pm | Spyre Therapeutics Inc. | SYRE | King-Jones Heidy See Remarks | 28,399 | $87.35 | $2,480,529 | 1,026,067 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-10-01 Exercise | 2026-10-02 9:30 pm | N/A 2033-09-01 | Spyre Therapeutics Inc. | SYRE | King-Jones Heidy See Remarks | 28,933 | $0 | 485,323 (Direct) | View |
| 2026-10-01 Exercise | 2026-10-02 9:30 pm | N/A N/A | Spyre Therapeutics Inc. | SYRE | King-Jones Heidy See Remarks | 28,933 | $14.5 | 485,323 (Direct) | View |
| 2026-09-01 Exercise | 2026-09-03 9:34 pm | N/A 2033-09-01 | Spyre Therapeutics Inc. | SYRE | King-Jones Heidy See Remarks | 28,399 | $0 | 1,026,067 (Direct) | View |
| 2026-09-01 Exercise | 2026-09-03 9:34 pm | N/A N/A | Spyre Therapeutics Inc. | SYRE | King-Jones Heidy See Remarks | 28,399 | $14.5 | 1,026,067 (Direct) | View |
| 2026-01-09 Option Award | 2026-01-13 9:25 pm | N/A 2036-01-09 | Spyre Therapeutics Inc. | SYRE | King-Jones Heidy See Remarks | 140,000 | $0 | 140,000 (Direct) | View |
| 2025-01-15 Option Award | 2025-01-17 4:34 pm | N/A 2035-01-15 | Spyre Therapeutics Inc. | SYRE | King-Jones Heidy See Remarks | 95,500 | $0 | 95,500 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 8:23 pm | N/A 2034-02-01 | Spyre Therapeutics Inc. | SYRE | King-Jones Heidy See Remarks | 63,000 | $0 | 63,000 (Direct) | View |
| 2023-09-01 Option Award | 2023-09-05 4:15 pm | N/A 2033-09-01 | Aeglea BioTherapeutics Inc. | AGLE | King-Jones Heidy See Remarks | 13,495,255 | $0 | 13,495,255 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-11 9:11 pm | N/A 2033-01-10 | Provention Bio Inc. | PRVB | King-Jones Heidy Chief Legal Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-11-22 Option Award | 2022-11-23 9:28 pm | 2022-11-22 2030-08-03 | Provention Bio Inc. | PRVB | King-Jones Heidy Chief Legal Officer | 90,000 | $0 | 300,000 (Direct) | View |
| 2022-03-22 Option Award | 2022-03-24 6:01 pm | 2022-03-22 2030-08-03 | Provention Bio Inc. | PRVB | King-Jones Heidy Chief Legal Officer | 60,000 | $0 | 210,000 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:22 pm | N/A 2032-01-18 | Provention Bio Inc. | PRVB | King-Jones Heidy Chief Legal Officer | 145,000 | $0 | 145,000 (Direct) | View |